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Abstract A major factor limiting the development of non-viral
gene delivery systems is the poor characterisation of polyelec-
trolyte complexes formed between cationic polymers and DNA.
The present study uses the fluorescamine reagent to improve
characterisation of poly(L-lysine) (pLL)/DNA complexes post-
modified with a multivalent hydrophilic polymer by determining
the availability of free amino groups. The results show that the
fluorescamine reagent can be used to monitor the self-assembly
reaction between pLL and DNA and the degree of surface
modification of the resultant complexes with a hydrophilic
polymer. This experimental approach should enable the prepara-
tion of fully defined complexes whose properties can be better
related to their biological activity.
z 1999 Federation of European Biochemical Societies.
Key words: DNA; Gene delivery; Gene therapy;
Fluorescamine; Polyelectrolyte complex
1. Introduction
Inter-polyelectrolyte complexes (also known as IPECs)
formed by the spontaneous self-assembly of DNA with cat-
ionic polymers are widely used as simple and e¡ective vectors
for the delivery of DNA into cells [1^3]. Despite their useful-
ness in vitro, these vectors are rapidly cleared from the blood-
stream upon intravenous administration, which greatly limits
their potential use as a systemic delivery system for DNA in
vivo [4]. In an attempt to improve their biocompatibility and
extend blood circulation times, hydrophilic polymers such as
poly(ethylene glycol) (pEG) have been incorporated onto the
surface of IPECs formed with synthetic polymers such as
poly(L-lysine) (pLL) or polyethylenimine [5^7]. However, at
present, none of the DNA delivery systems based on modi¢ed
IPEC designs is capable of prolonged plasma half-lives of up
to 20 h as exhibited by Stealth liposomes in mice [8,9].
A major factor limiting the development of IPECs modi¢ed
with hydrophilic polymers is the lack of techniques available
to properly characterise their formation. The preparation of
IPECs with fully de¢ned characteristics would enable the re-
lationship with their biological activity in vivo to be better
understood. There are two stages in the formation of modi¢ed
IPECs that require a better de¢nition. The initial binding
interaction between the cationic polymer and DNA is in£u-
enced by several factors. These include the molar ratio of
cationic polymer to DNA, pH conditions and the molecular
weight and type of cationic polymer used. Secondly, the de-
gree of modi¢cation of IPECs with hydrophilic polymers is
a¡ected by the length of the reaction time with the polymer,
pH conditions and the amount and type of polymer used.
The aim of the present study was to improve the character-
isation of IPECs by determining the availability of free amino
groups in IPECs formed with pLL. Each of the lysine residues
in pLL contains an epsilon amino group that forms a ionic
interaction with DNA. A method based on £uorescamine, a
reagent that speci¢cally reacts with amino groups, was used to
monitor the self-assembly reaction between DNA and pLL.
Previous studies have shown that £uorescamine cannot react
with amino groups once they are involved in stable salt link-
ages with DNA [10]. Using this approach, the in£uence of pH
conditions and the molecular weight of pLL on the formation
of IPECs was examined. This method was also used to mon-
itor the post-modi¢cation of IPECs with a synthetic hydro-
philic polymer bearing several 4-nitrophenyl ester groups that
is designed to react with amino groups and hence to crosslink
the surface of the IPEC.
2. Materials and methods
2.1. Chemicals and preparation of IPECs
Calf thymus DNA (CT DNA, approximately 8 kb) was obtained
from Sigma Chemical (Poole, UK) and puri¢ed using phenol/chloro-
form extraction and ethanol precipitation. pLL of average molecular
weights, 3.4, 20 and 459 kDa, were purchased from Sigma Chemical
(Poole, UK). Fluorescamine was purchased from Cambridge Bio-
science (Cambridge, UK). IPECs were formed by adding a small
volume of pLL (1 mg/ml) to CT DNA in 100 mM boric acid-
NaOH at pH 7.0^9.5. The complexes were then gently inverted three
times and allowed to form for 10 min at room temperature prior to
use. The amount of pLL to DNA used for each IPEC is represented
as the molar ratio of pLL nitrogen to DNA phosphate (N:P ratio).
2.2. Fluorescamine assay
Free primary amino groups in pLL were determined using the £u-
orescamine assay as previously described [11]. One-hundred Wl ali-
quots of each sample were diluted in 1.4 ml assay bu¡er (100 mM
boric acid-NaOH, pH 7.0^9.5) and 500 Wl 0.01% £uorescamine (pre-
pared in acetone) was rapidly added. Samples were rapidly inverted 4^
5 times and incubated at room temperature for 10 min. Fluorescence
was measured using a Perkin-Elmer LS 50B £uorimeter using Vex 392
nm, Vem 480 nm with 5^10 nm slit widths. Background £uorescence
was measured using assay bu¡er alone.
2.3. Ethidium bromide exclusion assay
The ability of pLL to form complexes with DNA was determined
by measuring changes in ethidium bromide-DNA £uorescence [12].
DNA solutions (20 Wg/ml) were mixed with ethidium bromide (400
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ng/ml) in cuvettes in a Perkin-Elmer LS 50B £uorimeter. Fluorescence
was measured at Vex 510 nm, Vem 595 nm and calibrated to 100%.
Following stepwise addition of pLL, samples were inverted three
times and readings were taken after 1^2 min. Background £uorescence
was set to 0% using ethidium bromide (400 ng/ml) alone.
2.4. Synthesis of multivalent hydrophilic polymers
Hydrophilic polymers were synthesised based on poly(N-(2-hydroxy-
propyl)methacrylamide) (pHPMA-ONp) bearing pendent tetrapeptide
(Gly-Phe-Leu-Gly, 8.6 mol%) or dipeptide (Gly-Gly, 10.3 mol%) side-
chains terminated in reactive 4-nitrophenyl ester groups, as previously
described [13]. These materials were characterised by FPLC (cali-
brated with pHPMA standards) and showed an average molecular
weight of 35 000 and 21 500 Da, respectively.
3. Results
The rate of reaction between pLL and £uorescamine was
examined under di¡erent pH conditions and it emerged that
the reaction proceeded more quickly at pH 9.0^9.5, where it
was completed within 1 min (Fig. 1A). At pH 7.0^8.0, the
reaction took longer to reach completion and a steady signal
was generated only after approximately 5^10 min. Therefore,
in all subsequent studies, the £uorescence readings were meas-
ured precisely 10 min after addition of £uorescamine to the
sample. Determination of pLL using the £uorescamine assay
was found to be linear up to 5 Wg/ml under all pH conditions
used (Fig. 1B). The actual level of £uorescence generated was
approximately 2^3-fold greater at pH 9.0^9.5 than at pH 7.0,
which probably re£ects deprotonation of more pLL epsilon
amino groups under higher pH conditions. No £uorescence
signal was produced when £uorescamine was added to DNA
alone (Fig. 1B).
IPECs are formed by charge-neutralised microdomains be-
tween pLL and DNA, resulting in the collapse of the DNA
molecule into a compacted structure of 50^100 nm in diameter
[1]. The binding reaction between pLL and DNA was char-
acterised by following the loss of amino groups upon the
addition of pLL to DNA under di¡erent pH conditions using
the £uorescamine assay. An inter-polyelectrolyte binding re-
action between CT DNA and pLL was indicated by a de-
crease in the available amino groups (Fig. 2), with the lowest
£uorescence signal observed after the addition of 10^12.5 Wg/
ml CT DNA to 5 Wg/ml pLL (corresponding to a N:P ratio of
0.6^0.8). There was relatively little in£uence of the pH on
amino group availability when pLL was mixed with 0^10
Wg/ml CT DNA (corresponding to N:P ratios v0.8). In con-
trast, at higher DNA concentrations up to 20 Wg/ml, there was
a signi¢cant increase in free amino groups at pH 9.0^9.5 (Fig.
2). These results suggest that pLL in the presence of excess
DNA is less tightly bound than it is within more charge-neu-
tralised environments (i.e. N:P ratios v0.8) and it is partic-
ularly weakly bound at a high pH.
A widely used method for monitoring the interaction be-
tween DNA and cationic polymers follows the loss of DNA
Fig. 1. (A) Rate of reaction between £uorescamine and pLL under
di¡erent pH conditions. Fluorescamine was added to pLL (5 Wg/ml)
in 100 mM boric acid-NaOH at pH 7.0 (i), pH 8.0 (ii), pH 9.0 (iii)
and pH 9.5 (iv) and the £uorescence signal (Vex 392 nm, Vem 480
nm) was recorded over 1200 s. (B) Linearity of the £uorescamine re-
action with pLL. Fluorescamine was added to pLL in 100 mM bor-
ic acid-NaOH at pH 7.0 (diamonds), pH 8.0 (squares), pH 9.0 (tri-
angles) and pH 9.5 (crosses) and to CT DNA in 100 mM boric
acid-NaOH at pH 9.5 (circles) at the indicated concentrations. Data
represent the means of triplicate samples þ S.D.
Fig. 2. Characterisation of the binding interaction between pLL and
DNA. pLL (5 Wg/ml) was incubated with CT DNA for 10 min at
the indicated concentrations in 100 mM boric acid-NaOH at pH 7.0
(diamonds), pH 8.0 (squares), pH 9.0 (triangles) and pH 9.5
(crosses) prior to the analysis of free amino groups using the £uo-
rescamine assay. The control was pLL alone at 5 Wg/ml at the cor-
responding pH. Data represent the means of triplicate sam-
ples þ S.D.
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£uorescence with ethidium bromide when DNA is condensed
into IPECs by interaction with polycations [12]. To investigate
the in£uence of polymer size on the interaction of pLL with
DNA, pLL of a di¡erent molecular weight was added to CT
DNA and the resultant binding reaction was examined using
the £uorescamine and ethidium bromide exclusion assays. At
N:P ratios less than 0.8, a low level of £uorescence was ob-
served with 459 kDa pLL using the £uorescamine assay, in-
dicating that high molecular weight pLL binds very e⁄ciently
to DNA (Fig. 3A). In contrast, 3.4 kDa pLL bound less
e⁄ciently to DNA with a 25^30% higher level of £uorescence
observed at N:P ratios of 0.2^0.6 as compared to 459 kDa
pLL (Fig. 3A). At N:P ratios greater than 0.8, there was no
signi¢cant di¡erence in the amino group availability with dif-
ferent sized pLL. Using the ethidium bromide exclusion assay,
a dramatic loss in the £uorescent signal was observed at a
N:P ratio of 0.8 with both 20 and 459 kDa pLL (Fig. 3B),
indicating the e⁄cient formation of IPECs. In contrast, 3.4
kDa pLL produced a gradual decrease in £uorescence that
only fell below 50% of the original level at a N:P ratio of
2.0. These results suggest that lower molecular weight pLL
binds less e⁄ciently to DNA, which may contribute towards
poor condensation of the DNA molecule.
Modi¢cation of the surface of IPECs with the multivalent
hydrophilic polymer pHPMA-ONp has led to the recent de-
velopment of a DNA delivery system with promising charac-
teristics for use in vivo [14]. Attachment of the multivalent
polymer to the IPEC involves a covalent linkage between the
reactive esters of the polymer and free amino groups on the
Fig. 3. E¡ect of the molecular weight of pLL on amino group avail-
ability. (A) pLL of average molecular weights, 3.4 kDa (diamonds),
20 kDa (squares) and 459 kDa (triangles) were incubated with CT
DNA for 10 min at the indicated concentrations in 100 mM boric
acid-NaOH, pH 7.0, prior to the analysis of free amino groups us-
ing the £uorescamine assay. The control was pLL alone at 5 Wg/ml
at pH 7.0. (B) Pro¢les of inhibition of CT DNA/ethidium bromide
£uorescence by pLL of average molecular weights 3.4 kDa (dia-
monds), 20 kDa (squares) and 459 kDa (triangles) in 100 mM boric
acid-NaOH, pH 7.0. The control was CT DNA alone at 20 Wg/ml.
Data represent the means of triplicate samples þ S.D.
Fig. 4. Modi¢cation of IPECs with the hydrophilic polymer. (A)
pLL 20 kDa (5 Wg/ml) was incubated for 72 h in 100 mM boric
acid-NaOH, pH 8.0, at room temperature with pHPMA-ONp con-
taining tetrapeptide (diamonds) or dipeptide (squares) side-chains
and pre-hydrolysed pHPMA-ONp (triangles). Pre-hydrolysed poly-
mer was prepared by incubating pHPMA-ONp overnight in bu¡er
at pH 9.5. (B) pLL/DNA complexes were formed at a N:P ratio of
1.0 and incubated overnight with the indicated concentrations of
pHPMA-ONp at pH 8.0. The control was pLL alone at 5 Wg/ml at
pH 8.0. Free amino groups were analysed using the £uorescamine
assay. Data represent the means of triplicate samples þ S.D.
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surface of the IPEC. Fluorescamine assays were performed to
characterise the interaction between pHPMA-ONp and pLL.
The reaction between pHPMA-ONp and pLL was indicated
by an 85% decrease in the £uorescence signal following the
addition of 200 Wg/ml pHPMA-ONp (Fig. 4A). A more e⁄-
cient reaction with pLL was indicated by a 98% loss of signal
at the same concentration of polymer using a modi¢ed form
of the pHPMA-ONp polymer containing a dipeptide (Gly-
Gly) side-chain instead of the tetrapeptide (Gly-Phe-Leu-
Gly) side-chain (Fig. 4A). Partial masking of amino groups
on pLL by electrostatic and not by covalent interactions with
pHPMA-ONp was also indicated by a 10^20% fall in the
£uorescence signal upon addition of the pre-hydrolysed
form of the polymer (Fig. 4A). Together, these results indicate
that both the nature of the peptide side-chain and hydrolysis
of the reactive ester group are factors that contribute towards
the interaction of the pHPMA polymer to free amino groups
in pLL.
To characterise the interaction of the pHPMA-ONp poly-
mer with free amino groups on the surface of IPECs,
pHPMA-ONp was added to pLL/DNA complexes formed
at a N:P ratio of 1.0 and the free amino groups were deter-
mined using the £uorescamine assay. The level of detectable
free amino groups gradually decreased following the addition
of 50^300 Wg/ml pHPMA-ONp (Fig. 4B). An approximate
50% decrease in the £uorescence signal was observed follow-
ing the addition of 300 Wg/ml pHPMA-ONp to the IPEC.
This result indicates that a signi¢cant proportion of free ami-
no groups associated with the pLL/DNA complexes was
modi¢ed by the hydrophilic polymer.
4. Discussion
Previous studies have used an assay based on the £uoresc-
amine reagent to monitor the incorporation of pEG onto the
mouse IgG antibody [15] and for analysing cationic lipid-nu-
cleic acid complexes [16]. In this study, the reaction of £uo-
rescamine with amino groups was used to characterise non-
viral DNA delivery vectors modi¢ed with a hydrophilic poly-
mer. The results show that the £uorescamine assay can be
used to probe the binding interaction between pLL and
DNA in the formation of IPECs. It is clear, for example,
that binding of pLL to DNA is pH dependent at N:P ratios
less than 0.8 and that higher molecular weight pLL binds
more e⁄ciently to DNA. Furthermore, the degree of incorpo-
ration of a hydrophilic polymer onto the surface of IPECs can
also be monitored using the £uorescamine assay.
One factor that appears to be important in determining the
e⁄ciency of the binding interaction between pLL and DNA is
the molecular weight of pLL used. Higher molecular weight
pLL bound more completely to DNA at low N:P ratios with
few residual amino groups than low molecular weight pLL.
The relatively high avidity achieved with 459 kDa pLL is most
likely caused by the simultaneous attachment of many positive
charges (in this case, up to 1000) to the DNA. The binding
reaction might be rendered essentially irreversible under these
conditions, leading to small amounts of free residual amino
groups. A 3.4 kDa pLL, on the other hand, might be able to
dissociate from the DNA producing a binding equilibrium
with higher amounts of free amino groups. One consequence
of this lower avidity for DNA is that 3.4 kDa pLL will be less
e⁄cient at neutralising the negative charges of the phosphate
groups along the DNA backbone resulting in the poor con-
densation of DNA observed with the polycation.
pLL is a weak polybase and under high pH conditions, it is
likely that the interaction with DNA will be unfavourable
since a greater proportion of the amino groups will be in
the deprotonated state. Indeed, at N:P ratios less than 0.8,
the degree of interaction between pLL and DNA was depend-
ent on pH conditions. However, at higher N:P ratios, the
binding of pLL to DNA was no longer pH dependent. The
increased stability of the interaction between pLL and DNA is
most likely the result of the formation of condensed structures
that are typically observed at N:P ratios of 0.8 or more [1]. In
contrast, when DNA is in excess, it is likely that IPECs will be
formed with an extended structure and increased separation of
pLL molecules from each other. In this case, the co-operative
e¡ects of charge-neutralised microdomains involving several
pLL molecules will be lost. Hence, the increased availability
of amino groups at a high pH probably re£ects the weak
binding of individual pLL molecules to DNA.
The long circulatory properties of pEG-containing lipo-
somes (or Stealth liposomes) has enabled their use as carriers
for cancer drugs in the treatment of tumours. The pEG head-
group on the liposome promotes blood circulation by inter-
fering with the absorption of plasma proteins and reducing
interaction with the reticuloendothelial system [9]. Hydro-
philic polymers such as pEG have also been incorporated
into DNA delivery vectors based on modi¢ed IPECs designed
for use in gene therapy protocols [5^7]. However, at present,
none of these vectors circulates in vivo with a plasma half-life
of greater than 30 min [7]. It is envisaged that an IPEC capa-
ble of prolonged circulation needs to be completely en-
shrouded in a hydrophilic shield. Hence, it is important to
properly characterise the incorporation of the hydrophilic pol-
ymer onto IPECs to ensure that there is su⁄cient polymer to
provide a steric barrier against the interaction of plasma pro-
teins and the reticuloendothelial system.
Unfortunately, there are few techniques available to char-
acterise the formation of polymer-coated IPECs and therefore
optimise conditions for attachment of the hydrophilic poly-
mer. We have shown that the £uorescamine assay can be used
to directly monitor the modi¢cation of an IPEC with a multi-
valent hydrophilic polymer. It was possible, for example, to
signi¢cantly reduce the number of available amino groups on
IPECs using the pHPMA polymer, indicating a high level of
surface modi¢cation. This experimental approach will be use-
ful in determining the amount of polymer required to com-
pletely modify the surface of IPECs with a corresponding
minimum number of free amino groups. The preparation of
fully polymer-coated IPECs will facilitate the development of
vectors capable of prolonged systemic circulation.
The use of the £uorescamine assay should also enable the
rational design and testing of new hydrophilic polymers to
optimise the coating reaction with IPECs. In the present
study, for example, the tetrapeptide (Gly-Phe-Leu-Gly) se-
quence attached to the pHPMA polymer was chosen as it
can act as a substrate for cathepsin B [17], which should
facilitate release of the DNA molecule within the cell. How-
ever, the pHPMA polymer containing the shorter dipeptide
(Gly-Gly) side-chain was more reactive towards free amino
groups in pLL and may be better suited for coating of the
IPEC. A possible explanation for this observation is that the
hydrophobic amino acids might cause partial micellisation of
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the pHPMA-(Gly-Phe-Leu-Gly)-ONp polymer, making some
ester groups unavailable for reaction with pLL.
In summary, the use of the £uorescamine reagent enables
better characterisation of IPECs modi¢ed with hydrophilic
polymers, which in turn will facilitate the correlation between
the physicochemical properties of IPECs with their biological
activity. Work is currently ongoing to use this approach in the
systematic development of DNA delivery vectors capable of
prolonged circulation in vivo.
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